[239]Georgia Tech Research Corp., Atlanta, Georgia, was awarded a $9,284,660 cost reimbursement contract to develop and manufacture a point-of-need pathogen detection technology that will identify the underlying pathogens responsible for the human diseases of sepsis (bacteremia) and respiratory infection